SREBF2 and metabolic dysfunction-associated steatohepatitis: We also found significant upregulation of hepatic expression of SREBF1, SREBF2, HNF4A, and KLF13 in NAFL and NASH compared to the control group (adjusted p value < 0.05, Figures 5B–5F; Data S2).